Opsoclonus-Myoclonus Ataxia (OMA) – pediatric onset
Recommended Indications in which IG can be used
Order Number: N11-OMA
| Recommendations | IVIG is recommended for acute and long-term treatment, in consultation with a neurologist, in addition to other tumour therapies as applicable. |
| Dose/Frequency of Administration | Induction: 1 to 2 g/kg adjusted body weight divided over 1 to 5 days (maximum 1 g/kg/day). Maintenance: 0.4 to 1 g/kg adjusted body weight divided over 1 to 5 days (maximum 1 g/kg/day), every 4 to 6 weeks. Once the patient’s condition has stabilized, consider titrating the dose and/or the treatment interval to the lowest dose necessary to maintain clinical effectiveness. |